These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10416242)

  • 41. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
    Lenz TL; Hilleman DE
    Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiplatelet therapy for secondary stroke prevention.
    Forbes CD
    Scott Med J; 1999 Apr; 44(2):54-9. PubMed ID: 10370984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke.
    Lenz T; Wilson A
    Clin Pharmacokinet; 2003; 42(10):909-20. PubMed ID: 12885264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
    Wang Y; Chen W; Wang Y
    Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early dual therapy for Chinese adults with TIA.
    BMJ; 2013 Jul; 347():f4197. PubMed ID: 23823995
    [No Abstract]   [Full Text] [Related]  

  • 47. The approach to optimizing stroke care.
    Panagos PD
    Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiplatelet therapy to prevent recurrent stroke: Three good options.
    Mansoor AH; Mujtaba MT; Silver B
    Cleve Clin J Med; 2013 Dec; 80(12):787-95. PubMed ID: 24307163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antiaggregant treatment for cerebral ischemia: ticlopidine versus aspirin].
    Rey A; Aguilar M; Bonaventura I; Martínez I; Quintana S
    Rev Neurol; 1996 Feb; 24(126):214-8. PubMed ID: 8714491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. From CURE to MATCH: ADP receptor antagonists as the treatment of choice for high-risk atherothrombotic patients.
    Hacke W
    Cerebrovasc Dis; 2002; 13 Suppl 1():22-6. PubMed ID: 11803184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs--is antiplatelet monotherapy still reasonable?
    Diener HC; Weber R; Weimar C; Röther J
    Int J Clin Pract; 2011 May; 65(5):531-5. PubMed ID: 21489077
    [No Abstract]   [Full Text] [Related]  

  • 54. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].
    Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The value of platelet inhibitors in the secondary prophylaxis of stroke -- a review].
    Schellinger PD; Jüttler E; Meyding-Lamadé UK; Schwark C
    Fortschr Neurol Psychiatr; 2004 May; 72(5):270-81. PubMed ID: 15136948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevention of vascular events after transient ischemic attack or cerebral infarct].
    Leys D; Cordonnier C
    Rev Prat; 2006 Sep; 56(13):1437-42. PubMed ID: 17002069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antiplatelet therapy of secondary stroke prevention after ESPS-2 and CAPRIE].
    Alvarez-Sabín J; Montaner-Villalonga J
    Rev Neurol; 1999 Oct 16-31; 29(8):780-4. PubMed ID: 10560115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [PRoFESS study presented. Change in secondary prevention].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():96-7. PubMed ID: 14579494
    [No Abstract]   [Full Text] [Related]  

  • 59. Antiplatelet therapy in the prevention of ischaemic stroke.
    Verry M; Panak E; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis.
    Verro P; Gorelick PB; Nguyen D
    Stroke; 2008 Apr; 39(4):1358-63. PubMed ID: 18323511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.